FCX
Freeport-McMoRan
$69.16
▲ 1.4%Updated Today 11:30 AM ET
FCX at a glance — five pillars scored 0–100 from real filed financials.
Overall: Neutral · 50/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 66.8% over the last 12 months
Market Cap
$87.65B
P/E
36.45x
Forward P/E (est.)
26.04x
ROE
14.5%
Revenue Growth
-24.2%
EPS Growth
54.7%
Profit Margin
10.4%
FCF Yield
5.6%
Debt / Equity
0.5x
ROIC
18.0%
Interest Coverage
20.89x
Current Ratio
2.39x
Dividend Yield
0.9%
Implied Growth (rev. DCF)
7.6%
Rating Score
50/100
Freeport-McMoRan (FCX) is a large-cap company in the Copper industry, part of the Materials sector of the S&P 500, with a market value around $87.65B.
In its latest reported year it generated about $25.19B in revenue.
Our model rates FCX Neutral (50/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Evidence of durable competitive advantage in the filed financials (10 years of history).
Some durable-advantage evidence, but not across the board — dig into which ingredient is weak and whether it's cyclical or structural.
26.9% average over the last 3 years
±15.0 pts around 20.3% across 10 years
grew in 6 of the last 9 year-over-year periods
positive in 9 of 10 years
18.0% latest fiscal year
A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what FCX's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. FCX trades near $69.16, above its 50-day average ($63.64) and 200-day average ($55.11). Price above both averages, with the shorter one above the longer, is the textbook definition of an uptrend — momentum favours buyers.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 36 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.
Volatility — ATR. Average True Range is the typical daily move. FCX's is $2.64 (~3.8% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month FCX found buyers near $59.44 (support) and sellers near $72.28 (resistance); its 52-week range is $35.15–$72.28. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.9× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
2.9%
Revenue moved from $14.56B in 2016 to $25.19B in 2025, a 6.3% compound annual growth rate. The most recent year declined 24.2% year over year. Shrinking revenue is worth a closer look — is it cyclical or structural?
Gross Margin
25.6%
Operating Margin
25.9%
Net Margin
10.4%
ROE
14.5%
Freeport-McMoRan keeps about 10.4% of each sales dollar as net profit, with a 25.6% gross margin and 25.9% operating margin. Return on equity is 14.5% and return on invested capital about 18.0%. Margins are moderate — typical of a competitive but profitable business.
Total Debt
$9.41B
Net Debt
$5.68B
Net Debt / EBITDA
0.87x
Debt / Equity
0.5x
Leverage: debt-to-equity is 0.5x, and operating profit covers interest about 20.9x, with a current ratio of 2.4x. That is a conservative balance sheet — a cushion in downturns. It carries roughly $9.41B of total debt against $3.74B of cash.
Operating CF
$5.61B
Free Cash Flow
$1.12B
FCF Margin
4.4%
In the latest year Freeport-McMoRan produced about $5.61B of operating cash flow and $1.12B of free cash flow after capital spending. That is a free-cash-flow yield of about 5.6% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
Coverage is weak, the payout was cut recently, or it's being financed rather than earned — treat the current yield as fragile.
Dividend yield
0.9%
Per share (latest FY)
$0.60
Total paid (latest FY)
$865.00M
History on record
10 years
dividend uses 78% of free cash flow
no current raise streak
payout was cut at least once in the last 10 years
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
36.45x
P/S
3.9x
P/B
3.8x
EV / EBITDA
—
FCX trades at 36.5x trailing earnings (about 26.0x on estimated forward earnings), 3.9x sales, and 3.8x book value. Reverse-engineering today's price implies the market expects roughly 7.6% long-term free-cash-flow growth. That is a premium multiple that needs growth to justify it.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$7.97
Current price
$69.16
Starting FCF (latest 10-K)
$1.12B
Growth, years 1–5
-5.0%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where FCX sits versus its Materials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 54 Materials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How FCX stacks up against its Materials peers — valuation, profitability, and growth versus the sector median.
In the Materials sector (78 S&P 500 companies), FCX ranks #37 of 78 by our overall rating. It trades at a premium versus the sector on earnings (36.5x P/E vs. 22.7x median) with a lower return on equity (14.5% vs. 16.1%) and slower revenue growth (-24.2% vs. 7.9%).
P/E vs sector
36.5x
median 22.7x
ROE vs sector
14.5%
median 16.1%
Growth vs sector
-24.2%
median 7.9%
Sector rank
#37
of 78 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Materials companies by sub-industry and size. Sector median is across all 78 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $69.16 today · expected CAGR -6% – 4%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $25.94B | $26.72B | $27.52B | $28.35B | $29.20B |
| Net income | $2.59B | $2.67B | $2.75B | $2.83B | $2.92B |
| EPS | $2.05 | $2.11 | $2.17 | $2.24 | $2.30 |
| Share price (low) | $45.03 | $46.38 | $47.78 | $49.21 | $50.69 |
| Share price (high) | $73.69 | $75.90 | $78.18 | $80.52 | $82.94 |
| CAGR (low–high) | -35% / 7% | -18% / 5% | -12% / 4% | -8% / 4% | -6% / 4% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for FCX:
- Healthy free-cash-flow yield (~5.6%) funds buybacks and dividends.
- A conservative balance sheet (debt/equity 0.5x) lowers risk.
The case against FCX:
- Revenue growth is slow/negative (-24.2%), limiting the upside engine.
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Valuation risk — at 36.5x earnings, disappointing results could compress the multiple.
Growth risk — sluggish revenue (-24.2%) leaves little margin for execution missteps.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Freeport-McMoRan is a large-cap materials business with shrinking revenue, with modest profitability, and a sound balance sheet. It trades at 36.5x earnings, which our model scores Neutral (50/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 30 Wall Street analysts covering FCX recommend (August 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Latest SEC Filings
FCX's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
In the Idea Lab
FCX — frequently asked questions
Is FCX a good stock to buy?
We don't give buy or sell advice. Our model rates Freeport-McMoRan Neutral (50/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is FCX's rating on The Stocks School?
Freeport-McMoRan currently scores 50/100 (Neutral) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does FCX's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Freeport-McMoRan's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for FCX calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this FCX analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell FCX. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.